Q4FY17 sales grew 13% driven by 5% price hike and 8% volume growth. Gross margin improved 130 bps YoY, but OPM declined 110 bps YoY at 19.7% on higher staff costs and other expenses (each up 120 bps YoY). EBITDA grew 7% YoY. PAT grew 18% YoY on higher other income.